(Jerusalem Post) Israeli pharmaceutical company Teva has announced it will donate more than 6 million doses of hydroxychloroquine sulfate tablets to hospitals across the U.S. from March 31. Over 10 million tablets are expected to be shipped within a month. The tablets are approved by the U.S. FDA for the treatment of malaria, lupus, and rheumatoid arthritis. They are currently under investigation to determine their efficacy against the coronavirus and U.S. officials have asked for their immediate availability and use.
2020-03-20 00:00:00Full ArticleBACK Visit the Daily Alert Archive